-
1 Comment
Medikit Co.,Ltd is currently in a long term downtrend where the price is trading 1.5% below its 200 day moving average.
From a valuation standpoint, the stock is 95.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.9.
Medikit Co.,Ltd's total revenue sank by 4.2% to $5B since the same quarter in the previous year.
Its net income has dropped by 5.4% to $783M since the same quarter in the previous year.
Based on the above factors, Medikit Co.,Ltd gets an overall score of 1/5.
| Exchange | TSE |
|---|---|
| ISIN | JP3921060004 |
| CurrencyCode | JPY |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Dividend Yield | 3.3% |
|---|---|
| PE Ratio | 13.33 |
| Target Price | None |
| Beta | 0.17 |
| Market Cap | 40B |
Medikit Co.,Ltd., together with its subsidiaries, develops, manufactures, sells, and exports medical devices related to blood vessels and blood in Japan and internationally. The company offers IV catheters, such as Supercath 5 and Supercath Ztu-V; hemodialysis products, including Supercath PRO, Supercath NEO, and Supercath Clampcath; and intervention products comprising Supersheath sheath introducers and Mongoose angiography catheters. It also provides indwelling needles for artificial dialysis; and needles for blood transfusions and infusions. Medikit Co.,Ltd. was founded in 1973 and is headquartered in Bunkyo, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 7749.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026
